Summary & Overview
HCPCS G0472: Hepatitis C Antibody Screening for High-Risk Individuals
HCPCS Level II code G0472 denotes hepatitis C antibody screening for individuals at high risk and other covered indications. As a preventive laboratory screening service, it supports early detection of hepatitis C virus exposure and guides follow-up diagnostic and treatment steps. Nationally, HCV screening has policy and public health importance because identifying infections can reduce transmission and improve clinical outcomes.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coverage patterns and payer considerations, common billing modifiers, and the clinical context in which G0472 is used. The publication outlines typical sites of service and how the code fits into preventive screening workflows. It also highlights benchmarking points and any recent policy updates affecting preventive HCV screening reimbursement where available.
This summary is intended for a national audience of billing specialists, compliance officers, and clinicians seeking a clear understanding of the code’s purpose, payer landscape, and operational implications.
Billing Code Overview
HCPCS Level II code G0472 represents Hepatitis C antibody screening for an individual identified as high risk and for other covered indications. The service is a preventive laboratory screening intended to detect hepatitis C virus (HCV) antibodies, which indicates prior exposure or infection.
Service type: Screening laboratory test
Typical site of service: Outpatient clinic, community health center, public health setting, or other ambulatory care locations where screening is provided
Clinical & Coding Specifications
Clinical Context
A 32-year-old patient presents to an outpatient primary care clinic requesting screening for hepatitis C after disclosing a history of injection drug use and prior incarceration. The clinician reviews risk factors, documents indications for testing, and orders a hepatitis C antibody screen. The specimen is collected via venipuncture in the clinic or a nearby lab. The test is performed by the laboratory; if reactive, reflex confirmatory RNA testing is ordered or the patient is referred for follow-up care and counseling. Documentation includes rationale for screening (high-risk behavior), informed consent, specimen source, and any payer-required screening indication. Typical workflow steps: patient intake and risk assessment, clinician order for G0472, specimen collection, lab processing and result reporting, and follow-up communication for reactive or non-reactive results.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default (no modifier) | Use when no modifier applies and reporting the service as billed. |
11 | Professional component | Use when reporting only the professional component of a separately payable lab service (rare for waived antibody screens; include if applicable).
| Professional component | Use when billing only the professional component of a test that has a split technical/professional component.